A new predictive model enhances risk stratification in rectal adenocarcinoma, shifting from subjective MRI assessments to objective measures. Dynamic contrast-enhanced MRI washout and preoperative CEA levels independently predict 3-year disease-free survival. The model outperformed standard MRI assessments, showing AUCs of 0.757-0.819 versus 0.600-0.672. Identifying high-risk patients early means tailored treatments and potentially better outcomes. T/N […]
Category: General Surgery
Postoperative Adjuvant Therapies for High-Risk HCC Patients
Adjuvant therapies significantly reduce recurrence risk in hepatocellular carcinoma patients after hepatectomy. Radiotherapy (RT) shows the best results for disease-free survival (HR 0.31) and overall survival (HR 0.31). Tyrosine kinase inhibitors (TKI) also improve outcomes but are less effective than RT (HR 0.48 for DFS, HR 0.50 for OS). Surgeons should consider RT as the […]
Laparoscopic vs. Robotic Cholecystectomy: Key Insights
Surgeons should weigh the nuanced benefits and risks of robotic and laparoscopic cholecystectomy for gallstone disease. Robotic cholecystectomy (RC) has longer operative times, especially in Western centers (75 vs. 60 minutes). There’s a higher rate of bile duct injury with RC (0.72% vs. 0.23%), though early learning curves may play a role. RC shows reduced […]
Effective Tropis Technique for Anal Fistulas
Tropis is a promising minimally invasive procedure for treating anal fistulas, showing high cure rates without compromising anal function. Initial success rate for anal fistulas is 80% (95% CI: 0.77-0.83). Cure rate for high fistulas is also 80%, with a 73% success rate for second operations. Overall cure rate is 88%, including 88% for fistulas […]
Minimally Invasive Pancreatic Surgery Reduces Metabolic Risks
Minimally invasive parenchyma-sparing pancreatectomy (mi-psp) lowers the risk of new-onset diabetes and pancreatic exocrine insufficiency in patients with benign and low-grade pancreatic tumors. Postoperative diabetes occurred in 9.8% of mi-psp patients compared to 23% in the standard approach (p=0.008). The five-year cumulative risk of diabetes was 26.7% for mi-psp versus 38.9% for the traditional method. […]
Laparoscopic bile duct exploration proves safe and effective for stones
Laparoscopic common bile duct exploration (LCBDE) offers surgeons a reliable way to manage bile duct stones with promising outcomes. In a study of 1,689 patients, the overall conversion rate to open surgery was just 5%. Success rates were high: 77.6% for trans-cystic LCBDE and 93.4% for trans-choledochal LCBDE. Bile leak rates were notably lower for […]
New SSI Prevention Care Bundle Agreed by Surgeons
A European consensus identifies critical practices to reduce surgical site infections (SSIs), enhancing surgical outcomes. 92% consensus on 33 of 36 recommended practices for SSI prevention across preoperative, intraoperative, and postoperative phases. Surgeons comprised 59% of the 820 healthcare professionals surveyed, ensuring relevance for surgical settings. Implementing these evidence-based recommendations can significantly reduce SSIs and […]
Early Surgery for Ileocecal Crohn’s Disease Shows Promise
Early surgical intervention may be a vital strategy for managing uncomplicated ileocecal Crohn’s disease. Higher postoperative morbidity was noted in patients operated for complications compared to those with purely inflammatory disease. Delaying surgery increases the risk of recurrence; 10 out of 12 studies showed worse long-term control and greater reliance on corticosteroids and advanced therapies. […]
Patient Factors Impact Robotic Hepatectomy Outcomes
Patient selection is critical in robotic hepatectomy for optimizing surgical outcomes. Major hepatectomy complications increase with cirrhosis, obesity, and tumor size ≥ 10 cm, leading to longer operative times (up to 310 min) and higher estimated blood loss (up to 242 ml). Minor hepatectomy faces similar trends, with cirrhosis and obesity extending operative times to […]
Surgery improves outcomes for gastroenteropancreatic neuroendocrine tumors with liver metastasis.
Patients undergoing primary resection and metastasectomy for small-bowel neuroendocrine tumors (sbnets) had a mean disease-specific survival of 97 months, compared to 71.6 months for pancreatic neuroendocrine tumors (pnets). Surgical candidates who refused surgery had notably worse outcomes, with mean survivals of 73.5 months for sbnets and 56.5 months for pnets. Surgeons should prioritize surgical intervention […]